Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?
Open Access
- 4 August 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 8 (1), 108
- https://doi.org/10.1186/1471-2334-8-108
Abstract
Background Drug use and in particular injecting drug use has been at the forefront of the explosive spread of HIV in general populations in many countries in Asia. There is concern that also in China increased HIV incidence in drug users might spark off a generalized epidemic in the wider population. Close monitoring of HIV incidence and risk factors in drug users is therefore important to be able to target interventions effectively. Second generation surveillance was launched to assess HIV prevalence and risk behaviours jointly with the purpose of describing trends and predicting future developments. To assess whether these goals were fulfilled among drug users in China we provide an analysis of risk factors for HIV infection and of regional differences in HIV prevalence. Methods We analysed data collected in 2005 in 21 drug user second generation surveillance sentinel sites from 14 provinces in China. We used random effects logistic regression to test for risk factors for HIV infection and regional differences. Results The overall HIV-1 antibody prevalence was 5.4% (279/5128); 4.9% among injecting drug users (IDU) not sharing needles and 3.7% among non-injecting drug users. We found substantial heterogeneity among the surveillance sites with prevalence rates ranging between 0% and 54%. HIV status was strongly affected by the regional prevalence of HIV. Risk behaviours were highly prevalent in regions where HIV prevalence is still low. The distribution of duration of drug use in different sites indicated different stages of the drug use epidemics. Conclusion ]Regional differences in HIV prevalence in China reflect different stages of the drug use and HIV epidemics rather than differences in risk behaviours. Therefore, outbreaks of HIV among drug users in regions where prevalence is still low can be expected in the future. However, methodological limitations of surveillance embedded into routine systems limit the usability of existing data. More standardized approaches to data collection in secondary generation HIV surveillance are necessary to better understand regional differences in risk behaviour and prevalence and to design targeted intervention for those regions at risk of experiencing outbreaks.Keywords
This publication has 30 references indexed in Scilit:
- Prevalence of HIV and factors associated with risk behaviours among Chinese female sex workers in Hong KongAIDS Care, 2007
- 2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg.International Journal of Public Health, 2007
- China and HIV — A Window of OpportunityNew England Journal of Medicine, 2007
- Methods to Recruit Hard-to-Reach Groups: Comparing Two Chain Referral Sampling Methods of Recruiting Injecting Drug Users Across Nine Studies in Russia and EstoniaJournal of Urban Health, 2006
- Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and WalesBMC Infectious Diseases, 2006
- Drug use and HIV/AIDS in ChinaDrug and Alcohol Review, 2006
- Prevalence and Correlates of HIV Risk Behaviors among Drug Users in ChinaAIDS and Behavior, 2005
- HIV knowledge and risk behaviour of female sex workers in Yunnan Province, China: potential as bridging groups to the general populationAIDS Care, 2005
- Heterosexual Transmission of HIV in China: A Systematic Review of Behavioral Studies in the Past Two DecadesSexually Transmitted Diseases, 2005
- Needle sharing and sex-related risk behaviours among drug users in Shenzhen, a city in Guangdong, southern ChinaAIDS Care, 2005